Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion type Assertion NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_head.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion description "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion evidence source_evidence_literature NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion SIO_000772 21587211 NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion wasDerivedFrom befree-20150227 NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion wasGeneratedBy ECO_0000203 NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.